Key Highlights
- RegASK appoints Andrew Dalton as Chief Revenue Officer.
- Dalton has 15+ years in business development and sales leadership.
- Expertise in life sciences and technology sectors, including MedTech, BioTech, and BioPharma.
- Dalton aims to accelerate RegASK’s global growth and regulatory intelligence solutions.
- Former VP of Sales for EMEA at Causaly.
Source: PR Newswire
Notable Quotes
- “Andrew has a wealth of industry knowledge and proven experience in helping companies reach their growth goals, which makes him the ideal fit for this role.” — Caroline Shleifer, CEO at RegASK
- “I’m thrilled to join the RegASK team and help the company achieve its growth goals. The regulatory landscape is complex and ever-changing, and the need for businesses to leverage the latest technologies and expert knowledge to stay ahead has never been greater. I’m eager to help RegASK enable more organizations worldwide to be more proactive, agile, and strategic in regulatory compliance.” — Andrew Dalton, Chief Revenue Officer at RegASK
SoHC's Take
Andrew Dalton’s appointment as Chief Revenue Officer is a strategic move for RegASK. Dalton’s extensive background in business development and sales within the life sciences and technology sectors positions him well to drive RegASK’s global expansion. His expertise will be crucial in enhancing the company’s AI-driven regulatory intelligence solutions, making it easier for regulatory affairs teams to manage compliance risks and improve workflow efficiencies. This appointment is expected to significantly contribute to RegASK’s mission of streamlining regulatory execution and supporting companies worldwide in navigating the complex regulatory landscape.
